The purpose of this report is to describe a severe form of acute hepatic necrosis in mice treated with triiodothyronine and infected with brucellae. The lesions were seen neither in infected control mice nor in animals that had received only triiodothyronine.
The purpose of this report is to describe a severe form of acute hepatic necrosis in mice treated with triiodothyronine and infected with brucellae. The lesions were seen neither in infected control mice nor in animals that had received only triiodothyronine.
This investigation originated in studies on the host-parasite relationship of adrenocorfical activity to experimental brucellosis. The basic response of the tissues to invasion by brucellae is a granulomatous lesion with little or no necrosis (1) . However, when mice were pretreated with cortisone and then infected with Brucella suis there was a marked proliferation of brucella organisms in the liver and an absence of granuloma formation (2) . When the interrelationship of the thyroid and adrenal in the dog was explored in this laboratory, with Dr. James C. Melby, it was observed that the administration of the analogs of thyroxine, such as triiodothyronine and triiodothyroacetic acid, was followed by a significant rise in the level of blood cortisol. This response of the adrenal to the thyroid preparations was mediated through the hypophysis. Since the effect of triiodothyronine on adrenal activity did simulate the response of the adrenal to exogenous corticotropin, it was decided to evaluate the influence of triiodothyronine on the course of brucellosis in mice. A further stimulus to this endeavor was the work of Lurie and Ninos (3) in which triiodothyronine favorably suppressed the inflammatory reaction of tuberculosis in rabbits.
Methods
General Procedures.--Although there was some variation of procedure in each experiment, which will be noted, the basic steps were essentially the same. Mice were pretreated orally or intraperitoneaUy with triiodothyrouine for 2 to 7 days and then infected with bruceUae. Treatment with tth'odothyronine was continued for an additional 14 to 28 days. Preliminary experiments showed that the metabolic activity of the mice was increased after 4 daily intraperitoneal injections of 40 ug. of triiodothyronine. Using a dosed circuit respirometer it was observed that treated mice had an oxygen uptake 38 per cent greater than control mice. The mice were weighed before, during, and at the conclusion of the experiments. The animals were sacrificed with chloroform. Blood was obtained from the hearts of anesthetized animals. Pooled serum was 792 ACUTE HEPATIC NECROSIS used to determine bruceUa agglutinin titers. In previous investigations on experimental brucellosis in mice it was observed that brucellae localized in the spleen to a greater extent than in any other organ. Therefore, in the present studies the spleen of each animal was removed aseptically, weighed, and ground with sterile sand and saline. Aliquots were plated out on Albimi Brucdla agar, a and after incubation at 37°C. for at least 4 days, the colonies were counted and identified as bruceUae. Cultures of the liver and kidneys were also carried out. The liver, adrenals, and kidneys were removed, examined in the gross, fixed in formalin, and sections stained with hematoxylin and eosin. The Giemsa stain was also used for sections of liver in an attempt to demonstrate brucellae. Liver sections were also stained with oil-red O for fat.
M/ce.--Male and female ABC mice, weighing 18 to 20 gin., and 8 to 10 weeks of age were obtained from Dr. John Bittner of the Division of Cancer Biology, University of Minnesota Medical School. They were housed separately, according to sexes, in stainless steel cages with 5 mice in each cage. A diet of Purina chow checkers and tap water was available at all times.
Brucdla Strain.--A smooth culture of Brucd~a mditensis No. 368, isolated from a human patient, was used throughout the experiments. Saline suspensions were prepared from a culture grown on Albimi Brucdla agar at 37°C. for 48 hours. Diluted suspensions were quantitated turbidimetrically so that an inoculum of 0.1 ml. containing 5 X 104 to 1 X 105 brucellae was injected intraperitoneally into mice. Although the mice appeared more active during the first 2 to 5 days of treatment with triiodothyronine, the animals then became listless and lost weight. At the conclusion of the experiment 6 out of 20 had died in the triiodothyronine control group and 7 out of 20 in the infected treated group. There were no deaths in the infected control group (Table I) .
Fourteen days after infection the remaining mice were sacrificed. A surprising feature on gross examination was the appearance of yellow lesions, varying in size from pin-point to 2 ram., on the surface of the livers in 5 out of 13 of the infected mice treated with trliodothyronine. The lesions were discrete and located mainly at the periphery of the liver lobes. The earliest lesions were seen in the liver of a mouse that had died 5 days after infection. Lesions were not seen in the livers of infected control mice or in mice that had received only triiodothyronine. The 1 Albimi Laboratories, Brooklyn.
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spleens were equally enlarged in both infected groups. Adrenal gland enlargement was noted. The largest adrenal glands occurred in the infected mice treated with triiodothyronlne, and the next largest in the triiodothyronine-treated control group (Fig. 1) .
Microscopic l~indings.--In 10 out of 13 mice histological sections of the livers revealed areas of necrosis which were surrounded by lymphocytes, macrophages, and a few polymorphonuclear leukocytes.
In most sections the lesions involved many lobules and resembled infarcts with little cellular reaction at the periphery. In some there were surviving liver cells ad- necrosis were noted surrounded by many lymphocytes. Lesions were often adjacent to and sometimes partially occluded the veins (Fig. 6 ). Typical brucella granulomatous lesions were occasionally seen in the parenchyma. In the earliest lesions seen 5 days after infection some surviving liver cells were noted around congested central veins. Sinusoids in the center of the lobule were congested and contained many leukocytes. Necrosis involved adjacent lobules with little cellular reaction at the periphery of the lesion.
Brucellae could not be demonstrated in these areas with Giemsa stain. Sections of the livers from the infected control animals revealed occasional small granulomatous lesions (Figs. 7 and 8). Livers from the triiodothyronine-treated control mice showed no apparent abnormalities with the hematoxylin and eosin stain. Some centrilobular fatty degeneration was seen in a few sections with oil-red O stain.
A summary of the comparative data in this experiment is presented in Table II . The average colony counts of brucellae varied only slightly between the infected control group and the triiodothyronine-treated animals. Cultures of the livers revealed only Br. melitensis. Pooled sera of the triiodothyroninetreated and untreated groups of mice showed a brucella titer of 1:40.
Experiment I B.--In this experiment 20 mice received an average dose of 26 #g. daily in drinking water for 6 days prior to being infected intraperitoneally with 5 X 104 organisms of Br. mditensiz. Following infection triiodothyronine was administered orally for 14 days to one group (average daily dose 27 #g.), and for 28 days to a second group (average daily dose 23/~g.). As in the preceding experiment the mice were at first hyperactive and then became lethargic with little subsequent gain in weight. However, only 1 out of 20 mice died. The mice appeared healthy when sacrificed.
Of the mice sacrificed 14 days after infection 8 out of 9 had macroscopic pin-point yellow lesions of the liver. No lesions were seen in the control-infected mice, or in the mice treated only with triiodothyrorfine. Adrenal gland enlargement was similar to that seen in the first experiment. Microscopic Findings.--Histological sections of the livers showed the same changes as those described for Experiment 1 A, with hemorrhage noted in the necrotic areas of some sections.
In the group of mice sacrificed 28 days after infection 4 out of 9 mice had macroscopic yellow lesions of the liver, all of which were pin-point in size, except the liver of 1 mouse had a necrotic area involving the one-half of a hepatic lobe, and another showed an area of linear scarring. Histologic sections showed areas of necrosis as noted before, with evidence of fibrous tissue formation and calcium deposits in some sections.
Little variation in the brucella colony counts was detected between the different groups (Table III) . Cultures of the large necrotic area in the liver of the mouse cited above, as well as the livers of all the other infected mice, revealed only the presence of Br. melitensis.
The purpose of the next experiment was to control the dose of triiodothyronine more accurately by administering the drug intraperitoneaUy instead of orally, and to compare the effect of a small dose (2/~g. daily) with a large dose (40 #g. daily) in mice infected with Br. melitensis. Quantitative brucetla cultures were made of the livers, spleens, kidneys, and lungs.
Experiment 2: Effect of Triiodothyronine Administered Intrap~itoneally on Brucellosis in
M/~e.--Twenty-one mice were pretreated intraperitoneally with 100/~g. triiodothyronine on the 1st day and then 40 ug. dally thereafter. On the 3rd day 11 mice were infected intraperitoneally with 5 X 10 ~ Br. mditen~s organisms. There were no deaths, and 14 days after infection the mice were sacrificed. The triodothyronine control mice lost weight (2 per cent loss) but the treated infected mice gained weight (1.5 per cent gain) as did the infected controls (11 per cent gain). All of the mice appeared healthy during the period of observation. Macroscopic hepatic lesions were seen in 9 out of 11 infected mice treated with triiodothyronine. In 5 animals the lesions were pin point in size, while 4 had larger lesions, located both centrally and peripherally, and most prominent in the large anterior lobe and the caudal lobe, Histologlc sections revealed necrosis in the/ivers of 10 out of 11 infected mice treated with triiodothyronine.
There was little quantitative difference in the hrucella colony counts of the livers, spleens, kidneys and lungs from the infected and infected treated groups. However, in both groups the largest number of organisms were recovered from the spleens (Table IV) . There was enlargement of the adrenal glands in the triiodothyronine-treated mice as noted previously. The brucelia agglutinin titer of the pooled sera was 1:80 for the triiodothyronine-treated group and 1:160 for the infected control group.
In another experiment a group of 10 mice were treated with 2 ~g. of triiodothyronine intraperitoneally for 6 days before infection and then 14 days thereafter. These mice and the 2 control groups all gained weight. There was 9.7 per cent weight gain in the infected control group, 10 per cent gain in the triiodothyronine-treated group, and 19 per cent gain in the infected treated group. With this dose of triiodothyronine there was no macroscopic or microscopic evidence of hepatic necrosis, but nevertheless, the adrenal glands were enlarged in the triiodothyronine-treated mice as noted in the animals that received larger doses of the thyroid preparation.
In summarizing the results to this point, the following can be stated: (a) Hepatic necrosis was established in mice infected with bruceUae and treated with relatively large doses of triiodothyronine. The necrosis occurred in mice whose weight gain was below normal, and more extensive hepatic lesions appeared in those animals treated for a longer period of time with triiodothyronine or in which there was loss of weight.
(b) Orally administered triiodothyronine, in a dose of 28 to 35 tzg. daily over a period of 22 days, produced deaths, which did not occur in mice given intraperitoneal injections of 40 #g. of triiodothyronine daily for 16 days. The deaths could not be related to the brucella infection.
(c) There was no significant difference in quantitative spleen or liver cultures between triiodothyronine-treated infected mice and infected controls. There was no difference in the brucella agglutinin titers in the 2 groups. There was no evidence that triiodothyronine either suppressed or enhanced the bruceUa infection.
There was a possibility that the hepatic necrosis was precipitated in hyperthyroid mice by endotoxin released from brucella organisms, although previous studies had not demonstrated any lesions of the livers in normal mice following a single lethal injection of brucella endotoxin.
Experiment 3: The Effect of Daily Injections of Triiodotkyronine and Brucella Endotoxin on
the Livers of M/ce.--BmceUa endotoxin was prepared as described elsewhere (4) . The lethal dose (LD x°°) for this endotoxin in mice was 0.3 rag., administered intraperitoneally. Twenty mice were injected intraperitoneally with 40 ~,g. of triiodothyronine for 2 days. On the 3rd day, injections of endotoxin, 0.05 rag. i.p., were administered to 10 of these mice and continued for 14 successive days. The daily injections of triiodothyronine given 6 hours later than the endotoxin were continued for the same number of days in this group, as well as in a group of 10 mice that did not receive endotoxin. None of the mice died. Cultures of the spleen and liver remained sterile. No macroscopic or microscopic hepatic lesions were seen in any of the mice.
An additional experiment with 20 mice was carried out as just described, but the dose of brucella endotoxin was increased daily. Over a period of 14 days the dose was increased from 0.05 to 0.4 mg. The amount of triiodothyronine was the same as in the previous experiment. All of the mice gtven only endotoxin survived, but 5 out of 10 triiodothyronine-treated mice given the same amount of endotoxin had died by the 8th day. No hepatic necros~s was demonstrated macroscopically or microscopically in any of the mice.
DISCUSSION
The influence of thyroid activity on the susceptibility or resistance to infections is not clear. Conflicting results have been reported on the effects of thyroid administration in infected animals.
Lurie and Ninos (3) stated that tuberculosis was suppressed in rabbits treated with triiodothyronine. However, Dubos (5) observed that the administration of thyroid extract accelerated the death rate of mice infected with tuberculosis, and Smith and Dubos (6) reported that thyroxine enhanced the death rate of mice infected with staphylococci, but could not attribute the deaths to an acceleration of bacterial proliferation. Others (7) have concluded that triiodothyronine decreased the survival time of mice infected with bovine tubercle bacilli or Type I pneumococci. It has also been reported that induced hyperthyroid states in mice decreased survival time in viral infections (8) with no multiplication of the virus (9).
In the present experiments there was no evidence that triiodothyronine enhanced or suppressed a brucella infection in mice since the number of brucellae recovered from the livers and spleens of triiodothyronine-treated and control mice was essentially the same. Triiodothyronine did cause deaths independent of a bmcella infection, but did not enhance the death rate of the infected mice.
Thyroid preparations stimulate adrenal hypertrophy in the intact animal (10) . In the present investigation enlargement of the adrenal glands was observed in mice treated with triiodothyronine. In quantitative studies carried out by Dr. James C. Melby to be reported elsewhere, there was an elevation of the levels of corticosterone in both the plasma and in the adrenal glands of mice treated with triiodothyronine in these experiments. It was anticipated that the administration of triiodothyronine to mice infected with brucellae would provoke results similar to those described following the administration of ACTH or cortisone, in which a marked proliferation of brucellae occurred in the liver, and in which sections of liver tissue stained with Giemsa stain showed massive numbers of brucellae in the Kupffer cells and hepatic parenchyma (2) . However, in the present experiments the administration of triiodothyronine resulted in areas of hepatic necrosis, unlike any previously seen in experimental brucellosis, and without the multiplication of bruceUae. There was no evidence of multiplication of brucellae when a small dose of triiodothyronine was given (2 ~g. daily) which caused no hepatic necrosis, but still caused adrenal enlargement. It is of interest to note that the infection superimposed on the hyperthyroid state produced additional adrenal enlargement in all experiments.
Brucella infection alone does not produce acute necrosis of the liver in mice, although Br. suis may produce abscesses, and macroscopic lesions are occasionally seen with very large inocula of Br. melitensis. Fabyan (11) described translucent pin-point lesions in the livers of guinea pigs infected with Brucella abortus. He pointed out that the foci ranged from a few ceils to the size of 2 or more lobules. In the mouse, however, he noted only round or elongated masses of lymphoid cells. Fabyan remarked upon the relationship of the inflammatory foci to blood vessels, and Arias-Stella (12) has also emphasized the endophlebitis that occurs in brucella infection. Since the hepatic lesions seen in the present investigations resembled an acute necrosis or infarct a search was made for vascular involvement. No thrombi were found. Partial occlusion of vessels by lesions was seen and may account for an ischemic effect on cells with very high metabolic requirements such as these liver cells in the hyperthyroid state.
Fonnesu and Severi (13) have reported that thyroxine produces both morphologic and functional changes in the livers of rats. They described the appearance of cloudy swelling of the hepatic cells, which was correlated with the uncoupling of oxidative phosphorylation. Hashimoto (14) noted a centrilobular fatty degeneration and liver necrosis in rats fed desiccated thyroid. In the present experiments no areas of necrosis were seen in the mice treated with triiodothyronine alone, although there was a suggestion of some centrilobular fatty degeneration.
It could be assumed that triiodothyronine caused some functional liver disturbance and that bacterial products released from the brucellae further damaged the liver cells. Therefore, brucella endotoxin was administered to treated mice. Endotoxin is known to cause vascular constriction (15) . It has also been shown that mice are more susceptible to the lethal action of endotoxin after 1 or 2 doses of triiodothyronine (16) . But a combination of endotoxin and triiodothyronine did not produce hepatic necrosis.
Another possibility relating to the pathogenesis of hepatic necrosis involves brucella hypersensitivity. It has been recognized both in animals and in man that hypersensitivity of the tissues to brucella products is established within the 1st week after initiating a bruceUa infection (1). Hepatic necrosis was seen as early as 5 days after infection in mice treated with triiodothyronine. Long and Miles (17) have reported increased bacterial allergy in guinea pigs treated with thyroxine for 2 weeks and tested with tuberculin. However, in the present experiments a diminution in sensitivity could be anticipated due to the secretion of corticosteroids stimulated by triiodothyronine.
SUMMARY
When small numbers of Brucella melitensis were inoculated into ABC mice, occasional hepatic granulomas without necrosis were demonstrated. The greatest multiplication of brucellae was detected in the spleens. Because it had been previously observed that ACTH or cortisone markedly accelerated the multiplication of brucellae in the livers of infected mice with destruction of fiver cells, it was considered that triiodothyronine might likewise exaggerate a brucella infection by stimulating endogenous adrenal secretion. Although adrenal hypertrophy was produced, infection of mice treated with triiodothyronine resulted in severe hepatic necrosis or infarcts without the multiplication of brucellae in either the livers or spleens. The lesions were not encountered in untreated infected mice or in control mice treated with triiodothyronine. The necrosis was associated with minimal inflammatory reaction. The necrosis was not induced in mice treated with triiodothyronine and given brucella endotoxin. The precise genesis of the acute hepatic necrosis cited in these experiments remains undefined.
Triiodothyronine did not cause deaths in mice infected with Br. mditen3is. The infection was neither enhanced nor suppressed. 
